According to Xencor's latest financial reports the company's total assets are NZ$1.51 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | NZ$1.68 B | 10.6% |
2023-12-31 | NZ$1.52 B | 14.5% |
2022-12-31 | NZ$1.33 B | 8.62% |
2021-12-31 | NZ$1.22 B | 25.91% |
2020-12-31 | NZ$0.97 B | -2.07% |
2019-12-31 | NZ$0.99 B | 15.75% |
2018-12-31 | NZ$0.85 B | 56.49% |
2017-12-31 | NZ$0.54 B | -11.2% |
2016-12-31 | NZ$0.61 B | 104.65% |
2015-12-31 | NZ$0.30 B | 249.25% |
2014-12-31 | NZ$86.56 M | -18.53% |
2013-12-31 | NZ$0.10 B | 649.71% |
2012-12-31 | NZ$14.17 M | -50.56% |
2011-12-31 | NZ$28.66 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() Seagen
SGEN | NZ$6.08 B | 301.71% | ๐บ๐ธ USA |
![]() MacroGenics MGNX | NZ$0.37 B | -75.18% | ๐บ๐ธ USA |
![]() Amgen AMGN | NZ$149.64 B | 9,778.20% | ๐บ๐ธ USA |
![]() Merck MRK | NZ$192.77 B | 12,625.04% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | NZ$324.30 B | 21,307.47% | ๐บ๐ธ USA |
![]() AbbVie ABBV | NZ$228.00 B | 14,951.03% | ๐บ๐ธ USA |